Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Hepatic Portal System

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Liver Physiology

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of Rehabilitation and Hospital Art on Mood of Inpatients in a Rehabilitation Ward: A Preliminary Study.

Cureus·2025

Same author

Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Oncology·2023

Same author

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals.

BMC gastroenterology·2023

Same author

Identification and Prognostication of End-of-Life State Using a Japanese Guideline-Based Diagnostic Method: A Diagnostic Accuracy Study.

International journal of general medicine·2023

Same author

Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study.

Anticancer research·2022

Same author

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma.

World journal of hepatology·2022

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

Liver in systemic disease.

Yukihiro Shimizu

World Journal of Gastroenterology

|July 19, 2008

Summary

Abnormal liver function tests can stem from various liver conditions or systemic diseases. Identifying the root cause is crucial for effective treatment, prioritizing systemic disease management or intensive liver support when necessary.

Area of Science:

Hepatology
Internal Medicine
Clinical Diagnostics

Background:

Abnormal liver function tests (LFTs) present a diagnostic challenge with numerous potential etiologies.
Common causes include viral hepatitis, alcohol-related liver disease, nonalcoholic fatty liver disease (NAFLD), autoimmune conditions, hereditary disorders, malignancies, infections, gallstones, and drug-induced liver injury (DILI).
The liver's involvement in systemic diseases, affecting other primary organs, adds complexity to diagnosing abnormal LFTs.

Discussion:

In patients lacking a clear liver-specific etiology after initial screening (serology, imaging), systemic diseases become significant considerations for abnormal LFTs.
The diagnostic approach must differentiate between primary liver pathology and hepatic involvement secondary to systemic illness.
Systemic conditions can manifest with varying degrees of liver injury, from mild abnormalities to severe hepatic failure.

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Experiment Videos

Last Updated: Jul 3, 2026

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Key Insights:

Systemic diseases can be a primary driver of abnormal liver function tests when direct liver pathology is ruled out.
Treatment strategies for abnormal LFTs should be tailored based on whether the cause is intrinsic to the liver or secondary to a systemic condition.
Prompt recognition of liver involvement in systemic disease is vital for appropriate patient management.

Outlook:

Further research into the mechanisms linking systemic diseases to liver dysfunction can refine diagnostic algorithms.
Developing targeted therapies for liver injury secondary to systemic conditions holds promise for improved patient outcomes.
Enhanced understanding of the interplay between systemic health and liver function will aid in personalized medicine approaches for patients with abnormal LFTs.